Pfizer
Barbara Garcia has extensive experience in supply chain operations, currently serving as Vice President of Americas Supply Chain Operations at Pfizer since April 2006. In previous roles at Pfizer, Barbara held positions as USA Supply Chain & Logistics Leader and Sr. Director for both LATAM Supply Chain and South Western Europe Logistics and Supply Operations. Prior to Pfizer, Barbara worked as an Associate at A.T. Kearney from 2000 to 2006 and as a Business Analyst at E X L Consulting from 1998 to 2000. Barbara holds an MBA from INSEAD, completed in 2003, and a Bachelor's degree in Business Administration from Asturias Business School, obtained in 1997.
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.